Francis Chris bought WVE
December 8, 2025 · Form 4 insider transaction
Francis Chris bought 50,000 shares of Wave Life Sciences, Inc. at $10.48 per share, a transaction worth $524.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
50,000
Price
$10.48
Total value
$524.0K
InsiderFrancis Chris
RoleOfficer
SecurityOrdinary Shares
Transaction codeM: Option exercise
Transaction dateDecember 8, 2025
Filing dateDecember 10, 2025
Shares owned after75,000
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 5, 2025.